---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-004477"
form_type: "8-K"
ticker: "MNPR"
cik: "0001645469"
company_name: "Monopar Therapeutics"
filed_at: "2022-04-01T23:59:59+00:00"
generated_at: "2026-06-26T10:48:12.423365+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Monopar Therapeutics Co-Founder and CSO Dr. Andrew Mazar resigns effective April 8, 2022

## Summary
- Dr. Andrew P. Mazar resigns as EVP of R&D, Chief Scientific Officer, and Board member.
- Resignation effective April 8, 2022; no replacement announced.
- Dr. Mazar was a Co-Founder of the company.
- Monopar's common stock trades on Nasdaq under ticker MNPR.

## SEC filing metadata
- accession: 0001654954-22-004477
- form_type: 8-K
- ticker: MNPR
- cik: 0001645469
- company_name: Monopar Therapeutics
- filed_at: 2022-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645469/000165495422004477/0001654954-22-004477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645469/000165495422004477/mnpr_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-004477
- JSON: https://secwatch.observer/filing/0001654954-22-004477.json
- Plain text: https://secwatch.observer/filing/0001654954-22-004477.txt

## Key facts
- Executive change
  Dr. Andrew P. Mazar departed as Chief Scientific Officer at Monopar Therapeutics.
  - Action: resigning
  - Role: Chief Scientific Officer
  source text: Dr. Andrew P. Mazar, the Company’s Co-Founder, Executive Vice President of Research and Development, Chief Scientific Officer and Board Member, will be resigning from his position with the Company and as a member of the Company’s Board of Directors effective April 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645469/000165495422004477/0001654954-22-004477-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.